Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from thePharmaLetter

02:30 EST 11th December 2017 | BioPortfolio

Here are the most relevant search results for "thePharmaLetter" found in our extensive news archives from over 250 global news sources.

More Information about thePharmaLetter on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about thePharmaLetter for you to read. Along with our medical data and news we also list thePharmaLetter Clinical Trials, which are updated daily. BioPortfolio also has a large database of thePharmaLetter Companies for you to search.

Showing News Articles 1–25 of 2,400+ from thePharmaLetter

Sunday 10th December 2017

Look back at pharma news to Dec 8

Among last week’s most interesting news were two acquisition deals in the field of immuno-oncology:…

Friday 8th December 2017

UK pharma and biotech welcome Brexit breakthrough, but with caveats

The news early Friday morning that Britain and the European Union had finally agreed that enough progress…

SAGE-217 succeeds in major depressive disorder trial

Shares of CNS drug developer Sage Therapeutics surged yesterday, after the company revealed a second…

J&J and Sanofi lead ranking of clinical trial transparency

Pharmaceuticals and healthcare industry monitor Bioethics International has published its Good Pharma…

UK reverses reimbursement decision on Eisai's kidney cancer therapy

In a reversal of its earlier draft decision, the UK’s health technology assessor has provided final…

BRIEF—Generex out-licenses prostate cancer vaccine AE37 in China

Canada-headquartered Generex Biotechnology Corporation (OTCQB:GNBT) yesterday announced that its wholly-owned…

Kite gets wind in its sails as Gilead boosts cell therapy investment

Three months after Gilead Sciences bought fellow Californian biotech Kite Pharma, the HCV specialist…

ThromboGenics struggles to find patients for eye disease study

Belgian biotech ThromboGenics is scrapping its Phase II CIRCLE study of THR-409 (ocriplasmin), as not…

India’s commitment to ‘Ending the AIDS’ epidemic

The occasion of World AIDS Day was as good as any for India to launch a National Strategic Plan 2017-24,…

US neurologists’ increased focus on Ocrevus positioning in relapsing forms of MS

Seven months post-launch, the clear majority of US neurologists (n=103) have initiated at least one patient…

BRIEF—EFPIA response to EXPH draft opinion on payment for high-cost novel meds

The European Federation of Pharmaceutical Industries and Associations (EFPIA) believes that the recently…

Thursday 7th December 2017

BRIEF—Alexion inks deal to explore new drug delivery formulations

Nasdaq-listed Alexion Pharmaceuticals and Halozyme Therapeutics have agreed a deal based on the latter…

Medicines access group takes aim at Sovaldi patents

Two new patent challenges have been launched by the New York-based patient access and public health activist…

Patient advocacy group warns of steep price rises for certain medicines

A report from advocacy group AARP - the American Association of Retired Persons - has found that retail…

BRIEF—Australia approves Mavenclad for relapsing-remitting multiple sclerosis

Germany’s Merck KGaA has received approval from Australia’s medicines regulator for Mavenclad for…

Juno Therapeutics signs a trio of licensing deals

USA-based Juno Therapeutics rose 4% in pre-market trading, after it announced three license agreements…

Transgene and BioInvent agree viral-based immuno-oncology collaboration

Immuno-oncology specialist BioInvent International and viral-based immunotherapy company Transgene have…

bluebird bio partners with Scottish firm on CAR-T cell therapies

bluebird bio has signed a strategic R&D collaboration with Scottish immunotherapy company TC BioPharm…

Astellas inks partnership on rice-based oral vaccine

Japanese drug major Astellas Pharma is partnering with academia to develop rice-based vaccines, which…

Unlocking the potential of SMEs is key to combating AMR

Last week, the UK government published its latest annual update on its five year strategy to combat antimicrobial…

BRIEF—New positive data for Kisqali combination in advanced breast cancer

Novartis has announced positive results from the MONALEESA-7 trial investigating a Kisqali (ribociclib)…

GSK and Novartis being sued for alleged misleading representations in Australia

The Australian Competition and Consumer Commission (ACCC) has instituted proceedings in the Federal Court…

NICE draft guidance on ceritinib and glecaprevir with pibrentasvir

The UK’s National Institute for Health and Care Excellence (NICE) has today published draft guidance…

New report explores what’s in store for Pharma and Biotech in 2018

The upward momentum seen in the pharma and biotech sectors during 2017 looks set to continue into 2018,…

BRIEF—FDA draft guidance proposes collaborative approach to help develop drugs for rare pediatric diseases

The US Food and Drug Administration yesterday issued draft guidance outlining a potential novel approach…


Quick Search
Advertisement
 

News Quicklinks